Skip to main content
Erschienen in: Reactions Weekly 1/2016

01.10.2016 | Case report

Amiodarone/bacitracin/neomycin/warfarin

Elevated international normalised ratio : case report

Erschienen in: Reactions Weekly | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Drug interaction …
Literatur
Zurück zum Zitat Corbi G, et al. Clinical, drugs interactions and pharmacogenetics evaluation of warfarin treatment in an elderly patient: A case report. Journal of Gerontology and Geriatrics 64: 70-72, No. 2, 2016. Available from: URL: http://www.jgerontology-geriatrics.com - Italy Corbi G, et al. Clinical, drugs interactions and pharmacogenetics evaluation of warfarin treatment in an elderly patient: A case report. Journal of Gerontology and Geriatrics 64: 70-72, No. 2, 2016. Available from: URL: http://​www.​jgerontology-geriatrics.​com - Italy
Metadaten
Titel
Amiodarone/bacitracin/neomycin/warfarin
Elevated international normalised ratio : case report
Publikationsdatum
01.10.2016
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2016
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-016-21576-1

Weitere Artikel der Ausgabe 1/2016

Reactions Weekly 1/2016 Zur Ausgabe

Case report

Polaprezinc